MS4A7
gene geneOn this page
Also known as CD20L4CFFM4MS4A8
Summary
MS4A7 (membrane spanning 4-domains A7, HGNC:13378) is a protein-coding gene on chromosome 11q12.2, encoding Membrane-spanning 4-domains subfamily A member 7 (Q9GZW8). May be involved in signal transduction as a component of a multimeric receptor complex.
This gene encodes a member of the membrane-spanning 4A gene family, members of which are characterized by common structural features and similar intron/exon splice boundaries and display unique expression patterns in hematopoietic cells and nonlymphoid tissues. This family member is associated with mature cellular function in the monocytic lineage, and it may be a component of a receptor complex involved in signal transduction. This gene is localized to 11q12, in a cluster of other family members. At least four alternatively spliced transcript variants encoding two distinct isoforms have been observed.
Source: NCBI Gene 58475 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 82 total
- MANE Select transcript:
NM_021201
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13378 |
| Approved symbol | MS4A7 |
| Name | membrane spanning 4-domains A7 |
| Location | 11q12.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CD20L4, CFFM4, MS4A8 |
| Ensembl gene | ENSG00000166927 |
| Ensembl biotype | protein_coding |
| OMIM | 606502 |
| Entrez | 58475 |
Gene structure
Transcript identifiers
Ensembl transcripts: 27 — 22 protein_coding, 5 retained_intron
ENST00000300184, ENST00000358246, ENST00000528215, ENST00000528500, ENST00000528587, ENST00000528808, ENST00000530027, ENST00000530234, ENST00000530614, ENST00000533849, ENST00000534016, ENST00000534310, ENST00000899565, ENST00000899566, ENST00000899567, ENST00000899568, ENST00000899569, ENST00000899570, ENST00000899571, ENST00000899572, ENST00000899573, ENST00000899574, ENST00000899575, ENST00000971160, ENST00000971161, ENST00000971162, ENST00000971163
RefSeq mRNA: 4 — MANE Select: NM_021201
NM_021201, NM_206938, NM_206939, NM_206940
CCDS: CCDS7985, CCDS7986
Canonical transcript exons
ENST00000300184 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001107869 | 60385088 | 60385222 |
| ENSE00002164504 | 60393787 | 60395948 |
| ENSE00002195954 | 60378532 | 60378664 |
| ENSE00003505427 | 60383129 | 60383288 |
| ENSE00003613164 | 60386717 | 60386773 |
| ENSE00003668006 | 60392685 | 60392786 |
| ENSE00003686330 | 60389390 | 60389596 |
Expression profiles
Bgee: expression breadth ubiquitous, 205 present calls, max score 98.42.
FANTOM5 (CAGE): breadth broad, TPM avg 25.6287 / max 1510.6668, expressed in 466 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 114459 | 25.6287 | 466 |
| 114458 | 1.5822 | 273 |
| 114457 | 1.5207 | 270 |
| 114460 | 1.2884 | 283 |
| 114461 | 0.7842 | 191 |
| 114462 | 0.3404 | 80 |
| 114463 | 0.0581 | 31 |
Top tissues by expression
250 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| monocyte | CL:0000576 | 98.42 | gold quality |
| leukocyte | CL:0000738 | 98.21 | gold quality |
| spleen | UBERON:0002106 | 98.17 | gold quality |
| gall bladder | UBERON:0002110 | 97.13 | gold quality |
| vermiform appendix | UBERON:0001154 | 96.64 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 94.84 | gold quality |
| upper lobe of lung | UBERON:0008948 | 94.50 | gold quality |
| granulocyte | CL:0000094 | 94.47 | gold quality |
| right lung | UBERON:0002167 | 94.47 | gold quality |
| rectum | UBERON:0001052 | 94.28 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 94.17 | gold quality |
| lower lobe of lung | UBERON:0008949 | 92.41 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 91.75 | gold quality |
| right coronary artery | UBERON:0001625 | 91.47 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 91.25 | gold quality |
| lung | UBERON:0002048 | 90.99 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 90.92 | gold quality |
| blood | UBERON:0000178 | 90.62 | gold quality |
| left adrenal gland | UBERON:0001234 | 90.47 | gold quality |
| omental fat pad | UBERON:0010414 | 90.28 | gold quality |
| peritoneum | UBERON:0002358 | 90.19 | gold quality |
| right adrenal gland | UBERON:0001233 | 89.74 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 89.17 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 89.14 | gold quality |
| adrenal cortex | UBERON:0001235 | 89.13 | gold quality |
| mucosa of stomach | UBERON:0001199 | 88.83 | gold quality |
| adrenal gland | UBERON:0002369 | 88.82 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 88.24 | gold quality |
| calcaneal tendon | UBERON:0003701 | 88.19 | gold quality |
| bone marrow cell | CL:0002092 | 87.60 | gold quality |
Single-cell (SCXA)
Detected in 30 experiment(s), a significant marker in 27.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-10553 | yes | 2543.94 |
| E-CURD-122 | yes | 2248.67 |
| E-MTAB-7407 | yes | 2224.18 |
| E-CURD-55 | yes | 1445.08 |
| E-MTAB-6653 | yes | 1222.95 |
| E-MTAB-8207 | yes | 1124.84 |
| E-MTAB-9221 | yes | 945.59 |
| E-GEOD-149689 | yes | 905.07 |
| E-HCAD-32 | yes | 792.95 |
| E-CURD-112 | yes | 759.15 |
| E-ENAD-20 | yes | 192.32 |
| E-HCAD-1 | yes | 102.68 |
| E-MTAB-6701 | yes | 89.38 |
| E-HCAD-4 | yes | 75.41 |
| E-GEOD-135922 | yes | 61.11 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
94 targeting MS4A7, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-574-5P | 100.00 | 66.01 | 989 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-3667-3P | 99.99 | 67.17 | 1636 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-499A-5P | 99.98 | 70.79 | 1323 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
Literature-anchored findings (GeneRIF, showing 2)
- The short isoform of MS4A7 is a novel player in glioblastoma microenvironment, M2 macrophage polarization, and tumor progression. (PMID:36944954)
- Hepatic danger signaling triggers TREM2[+] macrophage induction and drives steatohepatitis via MS4A7-dependent inflammasome activation. (PMID:38478630)
Cross-species orthologs
26 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ms4a17a.6 | ENSDARG00000007018 |
| danio_rerio | ms4a17a.4 | ENSDARG00000014024 |
| danio_rerio | si:dkey-77f5.10 | ENSDARG00000020548 |
| danio_rerio | zgc:113425 | ENSDARG00000026616 |
| danio_rerio | ms4a17c.2 | ENSDARG00000028659 |
| danio_rerio | ms4a17a.7 | ENSDARG00000043796 |
| danio_rerio | ms4a17a.1 | ENSDARG00000043798 |
| danio_rerio | ms4a17a.8 | ENSDARG00000043802 |
| danio_rerio | ms4a17a.12 | ENSDARG00000053563 |
| danio_rerio | ms4a17a.16 | ENSDARG00000054898 |
| danio_rerio | si:dkey-7j14.6 | ENSDARG00000090552 |
| danio_rerio | ms4a17a.3 | ENSDARG00000091970 |
| danio_rerio | ms4a17a.5 | ENSDARG00000092204 |
| danio_rerio | si:dkey-174k12.3 | ENSDARG00000092593 |
| danio_rerio | si:dkey-238j22.1 | ENSDARG00000093512 |
| danio_rerio | si:ch73-56d11.5 | ENSDARG00000093546 |
| danio_rerio | ms4a17c.1 | ENSDARG00000094643 |
| danio_rerio | ms4a17a.11 | ENSDARG00000094809 |
| danio_rerio | ms4a17a.9 | ENSDARG00000094854 |
| danio_rerio | ms4a17a.10 | ENSDARG00000095695 |
| danio_rerio | si:ch73-56d11.3 | ENSDARG00000097527 |
| danio_rerio | tmem176l.3a | ENSDARG00000098387 |
| danio_rerio | ms4a17a.2 | ENSDARG00000105674 |
| danio_rerio | ms4a17a.17 | ENSDARG00000116378 |
| mus_musculus | Ms4a7 | ENSMUSG00000024672 |
| rattus_norvegicus | Ms4a7 | ENSRNOG00000020953 |
Paralogs (16): MS4A12 (ENSG00000071203), MS4A6A (ENSG00000110077), MS4A4A (ENSG00000110079), MS4A3 (ENSG00000149516), MS4A2 (ENSG00000149534), MS4A1 (ENSG00000156738), MS4A6E (ENSG00000166926), MS4A14 (ENSG00000166928), MS4A5 (ENSG00000166930), MS4A8 (ENSG00000166959), MS4A15 (ENSG00000166961), MS4A10 (ENSG00000172689), TMEM212 (ENSG00000186329), MS4A13 (ENSG00000204979), MS4A18 (ENSG00000214782), MS4A4E (ENSG00000214787)
Protein
Protein identifiers
Membrane-spanning 4-domains subfamily A member 7 — Q9GZW8 (reviewed: Q9GZW8)
Alternative names: CD20 antigen-like 4, CD20/FC-epsilon-RI-beta family member 4, Four-span transmembrane protein 2
All UniProt accessions (5): Q9GZW8, E9PIV6, E9PL98, E9PM26, E9PN40
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in signal transduction as a component of a multimeric receptor complex.
Subcellular location. Membrane.
Tissue specificity. Ubiquitous expression in normal tissues. Expression is more elevated in adult liver, lung, spleen, and heart than in their fetal counterparts, and is higher in normal tissues than in the cancerous tissue or cell lines. Low levels of expression were detected in the promonocytic stage, whereas high levels of expression were detected in mature monocytes.
Similarity. Belongs to the MS4A family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9GZW8-1 | 1 | yes |
| Q9GZW8-2 | 2 |
RefSeq proteins (4): NP_067024, NP_996821, NP_996822, NP_996823 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007237 | CD20-like_TM | Domain |
| IPR030417 | MS4A | Family |
Pfam: PF04103
UniProt features (15 total): topological domain 5, transmembrane region 4, sequence variant 3, chain 1, region of interest 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9GZW8-F1 | 74.77 | 0.33 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 219 (showing top):
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GOCC_TRANS_GOLGI_NETWORK, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, OCT1_03, SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN, VANTVEER_BREAST_CANCER_POOR_PROGNOSIS, SABATES_COLORECTAL_ADENOMA_DN, ACEVEDO_LIVER_CANCER_UP, LIAN_LIPA_TARGETS_3M, ZHENG_BOUND_BY_FOXP3, GOCC_ORGANELLE_SUBCOMPARTMENT, DODD_NASOPHARYNGEAL_CARCINOMA_DN, CHEN_METABOLIC_SYNDROM_NETWORK, VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN, WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
GO Biological Process (1): cell surface receptor signaling pathway (GO:0007166)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (3): trans-Golgi network (GO:0005802), plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| signal transduction | 1 |
| binding | 1 |
| Golgi apparatus subcompartment | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
782 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MS4A7 | MS4A1 | P08984 | 785 |
| MS4A7 | CCDC180 | Q9P1Z9 | 369 |
| MS4A7 | MS4A3 | Q96HJ5 | 360 |
| MS4A7 | KRTAP11-1 | Q8IUC1 | 355 |
| MS4A7 | MS4A18 | Q3C1V0 | 349 |
| MS4A7 | HEPHL1 | Q6MZM0 | 337 |
| MS4A7 | ZNF704 | Q6ZNC4 | 322 |
| MS4A7 | BLID | Q8IZY5 | 305 |
| MS4A7 | CACNG5 | Q9UF02 | 305 |
| MS4A7 | CPNE4 | Q96A23 | 292 |
| MS4A7 | HEXB | P07686 | 290 |
| MS4A7 | ZNF154 | Q13106 | 287 |
| MS4A7 | CSF2RB | P32927 | 284 |
| MS4A7 | CDKL2 | Q92772 | 277 |
| MS4A7 | RIT2 | Q99578 | 262 |
IntAct
30 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EMP1 | MS4A7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CD72 | MS4A7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| IGFBP5 | MS4A7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ITGB2 | MS4A7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLN | MS4A7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LAT | MS4A7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PMP22 | MS4A7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DRAM1 | MS4A7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MS4A7 | CPNE7 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CD72 | MS4A7 | psi-mi:“MI:0915”(physical association) | 0.000 |
| IGFBP5 | MS4A7 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ITGB2 | MS4A7 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PLN | MS4A7 | psi-mi:“MI:0915”(physical association) | 0.000 |
| LAT | MS4A7 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PMP22 | MS4A7 | psi-mi:“MI:0915”(physical association) | 0.000 |
| DRAM1 | MS4A7 | psi-mi:“MI:0915”(physical association) | 0.000 |
| chaA | MS4A7 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MS4A7 | SLC35F6 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MS4A7 | HMGCL | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (12): CPNE7 (Affinity Capture-MS), SLC35F6 (Two-hybrid), HMGCL (Two-hybrid), MS4A7 (Two-hybrid), MS4A7 (Two-hybrid), MS4A7 (Two-hybrid), MS4A7 (Two-hybrid), MS4A7 (Two-hybrid), MS4A7 (Two-hybrid), PLN (Two-hybrid), LAT (Two-hybrid), CPNE7 (Affinity Capture-MS)
ESM2 similar proteins: A0A2R8RY99, A4IIV4, A8MUP6, A9UL59, B2RVW2, C9JDP6, E9Q6I0, H7C241, O95859, P0DP42, P56749, Q0IIL2, Q0V9E0, Q29RH7, Q2KHT4, Q32KQ5, Q3SZT1, Q3T110, Q3UUA0, Q4V922, Q5CZV0, Q5FWC3, Q5J8X5, Q5R8B5, Q5R9K1, Q6AXT9, Q6AYL2, Q6GV27, Q6GV28, Q6ICI0, Q7T392, Q80SV1, Q80WE5, Q86WI0, Q8CJ58, Q8K445, Q8NHS1, Q8R1W2, Q8VI88, Q96CE8
Diamond homologs: A6QPF4, P13386, P20490, Q01362, Q3C1V0, Q3C2E2, Q3UPL6, Q5REZ6, Q8N5U1, Q920C4, Q96HJ5, Q96JA4, Q96JQ5, Q96PG2, Q99N05, Q99N07, Q99N08, Q99N09, Q99N10, Q9BY19, Q9GZW8, Q9H3V2, Q9NXJ0, Q9H2W1, P11836, P19437, Q96PG1, Q96DS6, Q2YDM3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
82 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 69 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1147 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:60699771:GCAAG:G | donor_gain | 1.0000 |
| 11:60715130:GCAAT:G | donor_gain | 1.0000 |
| 11:60699773:AAGG:A | donor_loss | 0.9900 |
| 11:60699774:AGGTG:A | donor_loss | 0.9900 |
| 11:60699775:GGTG:G | donor_loss | 0.9900 |
| 11:60699776:G:GG | donor_gain | 0.9900 |
| 11:60699776:GT:G | donor_loss | 0.9900 |
| 11:60708722:GATC:G | donor_gain | 0.9900 |
| 11:60708725:C:CG | donor_gain | 0.9900 |
| 11:60708725:C:G | donor_gain | 0.9900 |
| 11:60714536:A:G | donor_gain | 0.9900 |
| 11:60714556:G:GT | donor_gain | 0.9900 |
| 11:60714556:G:T | donor_gain | 0.9900 |
| 11:60715135:G:GG | donor_gain | 0.9900 |
| 11:60715304:TTCCA:T | acceptor_loss | 0.9900 |
| 11:60715305:TCCA:T | acceptor_loss | 0.9900 |
| 11:60715307:CA:C | acceptor_loss | 0.9900 |
| 11:60715309:GGTGA:G | acceptor_gain | 0.9900 |
| 11:60699774:AG:A | donor_gain | 0.9800 |
| 11:60699775:GG:G | donor_gain | 0.9800 |
| 11:60701076:GGGG:G | donor_gain | 0.9800 |
| 11:60701077:GGGG:G | donor_gain | 0.9800 |
| 11:60708649:GCT:G | acceptor_gain | 0.9800 |
| 11:60714576:G:GT | donor_gain | 0.9800 |
| 11:60715132:AATG:A | donor_loss | 0.9800 |
| 11:60715133:AT:A | donor_gain | 0.9800 |
| 11:60715133:ATGTG:A | donor_loss | 0.9800 |
| 11:60715134:TGTG:T | donor_loss | 0.9800 |
| 11:60715136:TGAGT:T | donor_loss | 0.9800 |
| 11:60715137:G:GG | donor_loss | 0.9800 |
AlphaMissense
1535 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:60389420:A:C | S124R | 0.986 |
| 11:60389422:T:A | S124R | 0.986 |
| 11:60389422:T:G | S124R | 0.986 |
| 11:60386717:T:C | F95L | 0.974 |
| 11:60386719:T:A | F95L | 0.974 |
| 11:60386719:T:G | F95L | 0.974 |
| 11:60385121:A:C | S61R | 0.971 |
| 11:60385123:T:A | S61R | 0.971 |
| 11:60385123:T:G | S61R | 0.971 |
| 11:60389432:G:C | A128P | 0.940 |
| 11:60385106:T:C | C56R | 0.934 |
| 11:60389433:C:A | A128E | 0.927 |
| 11:60385220:T:C | C94R | 0.924 |
| 11:60385103:T:C | C55R | 0.922 |
| 11:60385199:T:G | Y87D | 0.914 |
| 11:60392723:G:C | E195D | 0.908 |
| 11:60392723:G:T | E195D | 0.908 |
| 11:60389442:G:A | G131D | 0.896 |
| 11:60385127:G:A | G63R | 0.894 |
| 11:60385127:G:C | G63R | 0.894 |
| 11:60386730:G:A | G99E | 0.894 |
| 11:60383286:G:T | G49W | 0.893 |
| 11:60389441:G:C | G131R | 0.882 |
| 11:60389421:G:A | S124N | 0.879 |
| 11:60383286:G:A | G49R | 0.878 |
| 11:60383286:G:C | G49R | 0.878 |
| 11:60385211:G:A | G91R | 0.875 |
| 11:60385211:G:C | G91R | 0.875 |
| 11:60389413:T:A | N121K | 0.870 |
| 11:60389413:T:G | N121K | 0.870 |
dbSNP variants (sampled 300 via entrez): RS1000020281 (11:60387519 C>G), RS1000292754 (11:60381529 A>G), RS1000507269 (11:60394437 T>C), RS1000827299 (11:60395049 A>G), RS1000866317 (11:60386536 T>C), RS1000981056 (11:60392267 A>G), RS1001111197 (11:60395267 G>A), RS1001111852 (11:60392736 G>A), RS1001201696 (11:60387610 G>A), RS1001364410 (11:60393615 T>C), RS1001408895 (11:60380782 G>A), RS1001641256 (11:60387294 T>A), RS1001798989 (11:60380806 G>A,C), RS1002240887 (11:60385825 T>A), RS1002329909 (11:60391805 G>C)
Disease associations
OMIM: gene MIM:606502 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Nickel | decreases expression, increases expression | 3 |
| nickel sulfate | increases expression | 2 |
| Benzo(a)pyrene | decreases expression, increases methylation | 2 |
| propionaldehyde | increases expression | 1 |
| cyanoginosin LR | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Pioglitazone | increases expression | 1 |
| Air Pollutants, Occupational | decreases expression | 1 |
| Allergens | decreases expression | 1 |
| Calcitriol | decreases expression | 1 |
| Demecolcine | increases expression | 1 |
| Dinitrochlorobenzene | increases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Eugenol | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Methylcholanthrene | affects binding, increases reaction | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Antirheumatic Agents | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_VD95 | BJAB GFP-MS4A7 | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.